Next-gen tissue: preservation of molecular and morphological fidelity in prostate tissue

Por Gillard, Marc, Tom, Westin R, Antic, Tatjana, Paner, Gladell P, Lingen, Mark W, VanderWeele, David J
Publicado no Am J Transl Res (2015)

Low-grade prostate cancer diverges early from high grade and metastatic disease

Por VanderWeele, David J, Brown, Christopher D, Taxy, Jerome B, Gillard, Marc, Hatcher, David M, Tom, Westin R, Stadler, Walter M, White, Kevin P
Publicado no Cancer Sci (2014)

Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer

Por Kregel, Steven, Kiriluk, Kyle J., Rosen, Alex M., Cai, Yi, Reyes, Edwin E., Otto, Kristen B., Tom, Westin, Paner, Gladell P., Szmulewitz, Russell Z., Vander Griend, Donald J.
Publicado em 2013

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer

Por Kregel, Steven, Chen, James L., Tom, Westin, Krishnan, Venkatesh, Kach, Jacob, Brechka, Hannah, Fessenden, Tim B., Isikbay, Masis, Paner, Gladell P., Szmulewitz, Russell Z., Vander Griend, Donald J.
Publicado no Oncotarget (2016)